Alicia Grande - 27 Dec 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Reporting relationship: VP, Treasurer and CFO
Issuer ticker: CPRX
Reported as of: 27 Dec 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Dec 2023, 17:00:16 UTC
Prior SEC filing: 12 Dec 2023
Source filing: View source filing
Reporting owner signature: /s/ Alicia Grande

Key filing fact

Alicia Grande filed Form 4 for CATALYST PHARMACEUTICALS, INC. (CPRX) on 29 Dec 2023.

Key facts

This page summarizes Alicia Grande's Form 4 filing for CATALYST PHARMACEUTICALS, INC. (CPRX).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 29 Dec 2023, 17:00.

Change

Previous filing in this sequence was filed on 12 Dec 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CPRX transaction

Common Stock, par value $0.001 per share

Options Exercise

Transaction value
Shares: +8,666
Change %: +17%
Price
Shares after: 59,223
Date: 27 Dec 2023
Ownership: Direct
Footnotes: F1

CPRX transaction

Common Stock, par value $0.001 per share

Tax liability

Transaction value
Shares: -3,410
Change %: -5.8%
Price
Shares after: 55,813
Date: 27 Dec 2023
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CPRX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -8,666
Change %: -0.72%
Price: $0.000000
Shares after: 1,187,168
Date: 27 Dec 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,666
Exercise price
Footnotes: F1, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.

Footnote F2

Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.

Footnote F3

Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025.

Footnote F4

Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 27, 2023.